Dr. Vinayak Aggarwal

Senior Director

30 Years of Experience

Cardiothoracic and Vascular Surgeon

MBBS, MD, DNB, FASE, FACC, FAHA

Reg. No.:4473, Haryana State Medical Council

Fortis Memorial Research Institute (FMRI), Gurgaon

Max Institute of Cancer Care, Lajpat Nagar, New Delhi

English, Hindi

Consultation Fee ₹ 1800

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Vinayak Aggarwal

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Vinayak Aggarwal

Dr. Vinayak Agrawal is a highly experienced Cardiothoracic Surgeon with over 30 years of expertise.
He did his MBBS from Maulana Azad Medical Collegein 1994.
After that, he di MD ( Internal Medicine ) from University College of Medical Sciences, in 1998.
He also did a DNB ( Cardiology) from Fortis Escorts Heart Institute, in 2004.
Dr. Aggarwal has Fellowship of American College of Cardiology (FACC), Fellowship of American Society of Echocardiography (FASE), and Fellowship of American Heart Failure Association (FAHA).
He is known for providing compassionate care to his patients.
He is a well-known member of various reputed organizations such as Cardiological Society Of India (CSI), American Society Of Echocardiography (ASE), and Indian Academy Of Echocardiography.
He has numerous papers under his credit.

Confirm Your Consultation With Dr. Vinayak Aggarwal

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, Maulana Azad Medical College, 1994
MD ( Internal Medicine ) from University College of Medical Sciences. 1998
DNB ( Cardiology )Fortis Escorts Heart Institute, 2004
Fellow of American Society of Echocardiography (FASE), 2013
Fellowship of American College of Cardiology (FACC), 2014
Fellow of American Heart Failure Association (FAHA)

Training & Certificates

Training in Internal medicine he also acquired nearly 1 years of experience in the field of Neurology after his MD medicine

OPD Schedule Of Dr. Vinayak Aggarwal

Book Appointment

Past Experience

Director & Head (Clinical Cardiology and Cardiac Imaging), Pushpawati Singhania Research Institute (PSRI), Saket, 2021
Associate Director (Cardiology), Medanta, The Medicity, Gurguram, 2019
Consultant (Cardiology), Indraprastha Apollo Hospital, New Delhi, 2009
Consultant (Cardiology) at Escorts Heart Institute and Research centre New Delhi, 2007

Renal and vascular complications of diabetes. Vishal Saxena, Vinayak Agarwal, Vijay Kher. Chapter 4. Renal Function in Hypertension and Diabetes. 2013; in press.
Echocardiographic assessment of intra-cardiac masses. Vinayak Agrawal. Journal Indian Academy of Echocardiography. 2010; 22: (2): 109-117.
Requirement of pharmacological treatment for primary prevention of cardiovascular disease in asymptomatic office-executives in north-India. Kasliwal RR, Bansal M, Mehrotra R, Agrawal V, Shrivastava S. Indian Heart J. 2010 Jul-Aug; 62(4):324-9.
Isolated Systolic Hypertension. Supplement on hypertension. Vinayak Agrawal, Ravi R Kasliwal. Indian Heart Journal, Mar 2010.
Thrombolyis versus primary percutaneous intervention in ST-elevation myocardial infarction: evidence versus clinical practice. ECAB clinical update. (Elsevier). Vinayak Agrawal, Ravi R Kasliwal. Cardiology, 2009.
Primary tumor of the heart. Angiosarcoma. Bansal M, Mehrotra R, Agrawal V, Kasliwal RR, Trehan N. Indian Heart J. Jul-Aug 2009; 61(4):383.
Time-trends in prevalence and awareness of cardiovascular risk factors in an asymptomatic North Indian urban population. Bansal M, Shrivastava S, Mehrotra R, Agrawal V, Kasliwal RR. J Assoc Physicians India. Aug 2009; 57: 568-73.
Mitral valve assessment using real time three-dimensional transesophageal echocardiography. Rahul Mehrotra, Manish Bansal, Vinayak Agarwal, Ravi R Kasliwal. Indian Heart Journal. 2009; 61:123-25.
Clinical profile of epilepsy in a tertiary care centre. Kiran Bala, V Agrawal, P Mittal, A Prasad, MM Singh. Neurocon. 1999.
Angiotensin II receptor blockers: current perspective. Agrawal V, Manohar G, Kasliwal RR. JAPI. 2003; 51: 706-713.
\Permanent atrial fibrillation outcome study using dronedarone on top of standard therapy (PALLAS). Sponsor – Sanofi Aventis. [Co-investigator].
The Stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 trial (SOLID-TIMI 52). Sponsor – GlaxoSmithKline. [Co-investigator].
Phase III trial (the AKKA study) with eprotirome in the heterozygous familial hypercholesterolemia (HeFH) patients. (prematurely terminated, Oct 2011). Sponsor – Karo Bio. [Co-investigator].
IMPROVE–IT examining outcomes in subjects with acute coronary syndrome:vytorin (ezetimibe/simvastatin) vs simvastatin. Sponsor – Merck. [Co-investigator].
MIRACLE –EF study. Sponsor – Medtronic. [Co-investigator].